Fueled by a handful of trials and word-of-mouth buzz, low-dose naltrexone is gaining momentum among patients and some doctors as an off-label treatment for chronic pain.

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment ...

Results of a systematic review and meta-analysis showed that LDN was safe and effective for reducing pain and improving ...

In this Healio video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, highlights a pair of “timely and cool” stories on point-of-care AI use and the FDA approval of ...

A substantial minority of patients diagnosed with fibromyalgia at one medical center in Southern California had "consistently low" levels of alkaline phosphatase (ALP), researchers said, which could ...

Tonix Pharmaceuticals (TNXP) presented data on Tonmya, which was investigated as TNX-102 SL, at the 2025 American College of Rheumatology ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology ...

Discover essential insights on fibromyalgia, including symptoms, causes, diagnosis, and management strategies for effective ...